
    
      -  To initiate a prospective registry of MSLC patients with high-quality clinical samples
           and detailed medical data.

        -  To define the clonal relationship, genomic landscape and potential driver alterations of
           MSLC using whole-genome sequencing.

        -  To determine the intrapatient and intratumor genetic heterogeneity of MSLC.

        -  To correlate molecular features with clinical parameters and patient outcome.

        -  To serve as a continuous infrastructure for a large variety of research purposes
           including: A. Diagnostic research B. Prognostic research C. Biological research D.
           Interventional trial design testing new therapies in MSLC.
    
  